These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7528836)

  • 1. Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits.
    Evans RG; Rankin AJ; Anderson WP
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):542-51. PubMed ID: 7528836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of captopril on renal hemodynamics and segmental tubular reabsorption of sodium in humans.
    Hannedouche T; Delgado A; Gnionsahe A; Lacour B; Grunfeld JP
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):84-9. PubMed ID: 2468940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin.
    el Karib AO; Sheng J; Betz AL; Malvin RL
    Clin Exp Hypertens; 1993 Sep; 15(5):819-32. PubMed ID: 7691341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone.
    Ward JE; Angus JA
    J Cardiovasc Pharmacol; 1993 May; 21(5):804-14. PubMed ID: 7685453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
    Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
    Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of norepinephrine and angiotensin II-induced renal effects by NG-nitro-L-arginine, a nitric oxide synthase inhibitor.
    Matsumura Y; Egi Y; Maekawa H; Miura A; Murata S; Morimoto S
    Biol Pharm Bull; 1995 Apr; 18(4):496-500. PubMed ID: 7544660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NG-nitro-L-arginine on renal hemodynamic responses to endothelin-3 in anesthetized dogs.
    Yamashita Y; Yukimura T; Miura K; Okumura M; Yamanaka S; Yamamoto K
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S332-4. PubMed ID: 1725372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
    Danielson LA; Conrad KP
    J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of the nitric oxide synthase inhibitor, L-NG-nitroarginine, in dogs.
    Yukimura T; Yamashita Y; Miura K; Okumura M; Yamanaka S; Yamamoto K
    Am J Hypertens; 1992 Jul; 5(7):484-7. PubMed ID: 1379051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER; Burrell JH; Menzies RI; Stevens AD
    Br J Pharmacol; 1993 Oct; 110(2):821-7. PubMed ID: 8242257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril.
    Hajj-ali AF; Zimmerman BG
    Eur J Pharmacol; 1992 Mar; 212(2-3):279-81. PubMed ID: 1376274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between angiotensin and nitric oxide in the renal response to volume expansion.
    Llinás MT; González JD; Salazar FJ
    Am J Physiol; 1995 Sep; 269(3 Pt 2):R504-10. PubMed ID: 7573549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane.
    Wang YX; Abdelrahman A; Pang CC
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):571-8. PubMed ID: 7505359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans.
    Montanari A; Tateo E; Fasoli E; Giberti D; Perinotto P; Novarini A; Dall'Aglio P
    Hypertension; 1997 Sep; 30(3 Pt 2):557-62. PubMed ID: 9322981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of NO/EDRF for glomerular and tubular function: studies in the isolated perfused rat kidney.
    Radermacher J; Klanke B; Schurek HJ; Stolte HF; Frölich JC
    Kidney Int; 1992 Jun; 41(6):1549-59. PubMed ID: 1501411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase blockade and renal vascular responses to norepinephrine and endothelin-1 in conscious dogs.
    Fitzgerald SM; Evans RG; Christy IJ; Anderson WP
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):979-85. PubMed ID: 7564345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.